Uncategorized

Chasing Dupixent, a biotech aims to make better antibody drugs for eczema

Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.

​Read More

Published

on

Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.

​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version